These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 30113595

  • 1. [Standardization of intensive therapy tactics for acute hepatic insufficiency in patients with liver cirrhosis after portosystem shunting].
    Ibadov RA, Babadzhanov AK, Irmatov SK, Gizatulina NR, Ibragimov SK, Ruziboev SA.
    Khirurgiia (Mosk); 2018; (8):61-67. PubMed ID: 30113595
    [Abstract] [Full Text] [Related]

  • 2. [Portal hypertension-pre- and post operative therapy].
    Hütteroth TH, Meyer zum Büsshenfelde KH.
    Chirurg; 1980 Jul; 51(7):421-6. PubMed ID: 6967803
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H, Astrup LB, Nielsen DT, Vilstrup H.
    Ugeskr Laeger; 2003 Jan 27; 165(5):439-42. PubMed ID: 12599838
    [Abstract] [Full Text] [Related]

  • 5. Early, late, or no shunt embolization in patients with cirrhosis- and portosystemic shunt-related hepatic encephalopathy.
    Philips CA, Rajesh S, George T, Ahamed R, Mohanan M, Augustine P.
    Indian J Gastroenterol; 2020 Aug 27; 39(4):377-387. PubMed ID: 32929684
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE.
    N Engl J Med; 1995 May 04; 332(18):1192-7. PubMed ID: 7700312
    [Abstract] [Full Text] [Related]

  • 8. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
    Praktiknjo M, Simón-Talero M, Römer J, Roccarina D, Martínez J, Lampichler K, Baiges A, Low G, Llop E, Maurer MH, Zipprich A, Triolo M, Maleux G, Fialla AD, Dam C, Vidal-González J, Majumdar A, Picón C, Toth D, Darnell A, Abraldes JG, López M, Jansen C, Chang J, Schierwagen R, Uschner F, Kukuk G, Meyer C, Thomas D, Wolter K, Strassburg CP, Laleman W, La Mura V, Ripoll C, Berzigotti A, Calleja JL, Tandon P, Hernandez-Gea V, Reiberger T, Albillos A, Tsochatzis EA, Krag A, Genescà J, Trebicka J, Baveno VI-SPSS group of the Baveno Cooperation.
    J Hepatol; 2020 Jun 04; 72(6):1140-1150. PubMed ID: 31954206
    [Abstract] [Full Text] [Related]

  • 9. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Jun 04; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 10. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H, Emori K, Toyonaga A, Oho K, Kumamoto M, Haruta T, Mitsuyama K, Tsuruta O, Sata M.
    Kurume Med J; 2014 Jun 04; 61(1-2):1-8. PubMed ID: 25420513
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug 04; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pros and cons of TIPS for refractory ascites.
    Sanyal AJ.
    J Hepatol; 2005 Dec 04; 43(6):924-5. PubMed ID: 16246451
    [No Abstract] [Full Text] [Related]

  • 16. [Sequelae of portosystemic shunt operations].
    Berchtold R, Paumgartner G.
    Z Gastroenterol Verh; 1982 Apr 04; 17():59-67. PubMed ID: 6191460
    [No Abstract] [Full Text] [Related]

  • 17. [Specific development and course of portal hypertension complication in patients with hepatic cirrhosis of HBV and HCV etiology].
    Nazyrov FG, Deviatov AV, Babadzhanov AKh, Sultanov SA.
    Vestn Khir Im I I Grek; 2011 Apr 04; 170(1):22-9. PubMed ID: 21506350
    [Abstract] [Full Text] [Related]

  • 18. Acute Liver Injury and Decompensated Cirrhosis.
    Crismale JF, Friedman SL.
    Med Clin North Am; 2020 Jul 04; 104(4):647-662. PubMed ID: 32505258
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.